Completed OBSERVATIONAL NCT02385604

The Predictive Value of CT-PET in Esophageal Cancer

CT-PET for Prediction of Histopathologic Response, Nodal Status and Oncologic Outcome Following Neoadjuvant Chemoradiation for Esophageal Cancer

Sponsor: St. James's Hospital, Ireland

Conditions Esophageal Neoplasms

Updated 6 times since 2017 Last updated: Mar 9, 2016 Started: Jan 31, 2014 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Esophageal Neoplasms, this trial is completed. The trial is conducted by St. James's Hospital, Ireland and has accumulated 6 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. James's Hospital, Ireland

Data source: St. James's Hospital, Ireland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dublin, Ireland